Identifying patients with diagnosed cirrhosis in administrative health databases: a validation study.

IF 0.9 Q4 GASTROENTEROLOGY & HEPATOLOGY Canadian liver journal Pub Date : 2024-02-26 eCollection Date: 2024-02-01 DOI:10.3138/canlivj-2023-0013
Nabiha Faisal, Lisa M Lix, Randy Walld, Alexander Singer, Eberhard Renner, Harminder Singh, Leanne Kosowan, Alyson Mahar
{"title":"Identifying patients with diagnosed cirrhosis in administrative health databases: a validation study.","authors":"Nabiha Faisal, Lisa M Lix, Randy Walld, Alexander Singer, Eberhard Renner, Harminder Singh, Leanne Kosowan, Alyson Mahar","doi":"10.3138/canlivj-2023-0013","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Case ascertainment algorithms were developed and validated to identify people living with cirrhosis in administrative health data in Manitoba, Canada using primary care electronic medical records (EMR) to define the reference standards.</p><p><strong>Methods: </strong>We linked provincial administrative health data to primary care EMR data. The validation cohort included 116,675 Manitobans aged >18 years with at least one primary care visit between April 1998 and March 2015. Hospital records, physician billing claims, vital statistics, and prescription drug data were used to develop and test 93 case-finding algorithms. A validated case definition for primary care EMR data was the reference standard. We estimated sensitivity, specificity, positive and negative predictive values (PPV, NPV), Youden's index, area under the receiver operative curve, and their 95% confidence intervals (CIs).</p><p><strong>Results: </strong>A total of 116,675 people were in the validation cohort. The prevalence of cirrhosis was 1.4% (<i>n</i> = 1593). Algorithm sensitivity estimates ranged from 32.5% (95% CI 32.2-32.8) to 68.3% (95% CI 68.0-68.9) and PPV from 17.4% (95% CI 17.1-17.6) to 23.4% (95% CI 23.1-23.6). Specificity (95.5-98.2) and NPV (approximately 99%) were high for all algorithms. The algorithms had slightly higher sensitivity estimates among men compared with women, and individuals aged ≥45 years compared to those aged 18-44 years.</p><p><strong>Conclusion: </strong>Cirrhosis algorithms applied to administrative health data had moderate validity when a validated case definition for primary care EMRs was the reference standard. This study provides algorithms for identifying diagnosed cirrhosis cases for population-based research and surveillance studies.</p>","PeriodicalId":510884,"journal":{"name":"Canadian liver journal","volume":"7 1","pages":"16-27"},"PeriodicalIF":0.9000,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10946181/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian liver journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3138/canlivj-2023-0013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Case ascertainment algorithms were developed and validated to identify people living with cirrhosis in administrative health data in Manitoba, Canada using primary care electronic medical records (EMR) to define the reference standards.

Methods: We linked provincial administrative health data to primary care EMR data. The validation cohort included 116,675 Manitobans aged >18 years with at least one primary care visit between April 1998 and March 2015. Hospital records, physician billing claims, vital statistics, and prescription drug data were used to develop and test 93 case-finding algorithms. A validated case definition for primary care EMR data was the reference standard. We estimated sensitivity, specificity, positive and negative predictive values (PPV, NPV), Youden's index, area under the receiver operative curve, and their 95% confidence intervals (CIs).

Results: A total of 116,675 people were in the validation cohort. The prevalence of cirrhosis was 1.4% (n = 1593). Algorithm sensitivity estimates ranged from 32.5% (95% CI 32.2-32.8) to 68.3% (95% CI 68.0-68.9) and PPV from 17.4% (95% CI 17.1-17.6) to 23.4% (95% CI 23.1-23.6). Specificity (95.5-98.2) and NPV (approximately 99%) were high for all algorithms. The algorithms had slightly higher sensitivity estimates among men compared with women, and individuals aged ≥45 years compared to those aged 18-44 years.

Conclusion: Cirrhosis algorithms applied to administrative health data had moderate validity when a validated case definition for primary care EMRs was the reference standard. This study provides algorithms for identifying diagnosed cirrhosis cases for population-based research and surveillance studies.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在行政健康数据库中识别已确诊的肝硬化患者:一项验证研究。
目标:利用基层医疗电子病历(EMR)开发并验证了病例确定算法,以确定加拿大马尼托巴省行政健康数据中的肝硬化患者:利用初级医疗电子病历(EMR)定义参考标准,开发并验证了病例确定算法,以确定加拿大马尼托巴省行政健康数据中的肝硬化患者:方法:我们将省级行政健康数据与初级医疗电子病历数据连接起来。验证队列包括 116,675 名年龄大于 18 岁的马尼托巴人,他们在 1998 年 4 月至 2015 年 3 月期间至少接受过一次初级医疗服务。医院记录、医生账单报销、生命统计数据和处方药数据被用于开发和测试 93 种病例查找算法。针对初级医疗EMR数据的有效病例定义是参考标准。我们估算了灵敏度、特异性、阳性预测值和阴性预测值(PPV、NPV)、尤登指数、接收者操作曲线下面积及其 95% 置信区间(CIs):验证队列中共有 116,675 人。肝硬化发病率为 1.4%(n = 1593)。算法灵敏度估计值从32.5%(95% CI 32.2-32.8)到68.3%(95% CI 68.0-68.9)不等,PPV从17.4%(95% CI 17.1-17.6)到23.4%(95% CI 23.1-23.6)不等。所有算法的特异性(95.5-98.2)和 NPV(约 99%)都很高。与女性相比,男性和年龄≥45 岁的人与年龄在 18-44 岁的人相比,这些算法的灵敏度估计值略高:结论:以基层医疗电子病历的有效病例定义为参考标准,应用于行政健康数据的肝硬化算法具有适度的有效性。这项研究为基于人群的研究和监测研究提供了确定肝硬化诊断病例的算法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.10
自引率
0.00%
发文量
0
期刊最新文献
MAESTRO finally plays the music. Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CANHEPC) and the Canadian Association of Hepatology Nurses (CAHN) 2024 Abstracts. Decoding hepatorenal tyrosinemia type 1: Unraveling the impact of early detection, NTBC, and the role of liver transplantation. Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis. Equitable access to direct-acting antivirals: Canada's path to a hepatitis C-free tomorrow.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1